Rashid, J.R. et al. (1992) Acetylation status using hydralazine in African hypertensives
at Kenyatta National Hospital. East Afr. Med. J. 69:406-408
Golka, K. et al. (2002) The enhanced bladder cancer susceptibility of NAT2 slow
acetylators towards aromatic amines: a review considering ethnic differences. Toxicol.
Mattano, S.S. et al. (1989) Purification and biochemical characterization of hepatic
arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with
arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase. Mol.
Gether, U. et al. (1993) Different binding epitopes on the NK1 receptor for substance P
and non-peptide antagonist. Nature 362:345-348
Hubbell, W.L. et al. (2003) Rhodopsin structure, dynamics, and activation: a perspective
from crystallography, site-directed spin labeling, sulfhydryl reactivity, and disulfide
cross-linking. Adv. Protein Chem. 63:243-290
Arnis, S. et al. (1994) A conserved carboxylic acid group mediates light-dependent proton
uptake and signaling by rhodopsin. J. Biol.
Chackalamannil, S. et al. (2005) Discovery of potent orally active thrombin receptor
(protease activated receptor 1) antagonists as novel antithrombotic agents. J. Med.
Galvez, T. et al. (2001) Allosteric interactions between GB1 and GB2 subunits are required
for optimal GABAB receptor function. EMBO J.
Ma, A.W.-.S. et al. (2007) Recovery of oligomers and cooperativity when monomers of the
M2 muscarinic cholinergic receptor are reconstituted into phospholipid
vesicles. Biochemistry 46:7907-7927
Rajeswaran, W.G. et al. (2001) Design, synthesis, and biological characterization of
bivalent 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as selective
muscarinic agonists. J. Med. Chem. 44:4563-4576
Zamponi, G.W. and French, R.J. (1993) Dissecting lidocaine action: diethylamide and phenol
mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.
Roy, M. et al. (1996) HERG, a primary human ventricular target of the nonsedating
antihistamine terfenadine. Circulation 94:817-823
Huang, L. et al. (2004) NNC 55-0396
cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium
channels. J. Pharmacol. Exp. Ther. 309:193-199
Hannon, H.E. and Atchison, W.D. (2013) Omega-conotoxins as experimental tools and
therapeutics in pain management. Mar.
Willette, R.N. et al. (2008) Systemic activation of the transient receptor potential
vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.
Pharmacol. Exp. Ther. 326:443-452
Post, R.L. et al. (1972) Activation by adenosine triphosphate in the phosphorylation
kinetics of sodium and potassium ion transport adenosine triphosphatase. J. Biol.
Forbush, B. (1987) Rapid release of 42K and 86Rb from an occluded state of the Na,K-pump
in the presence of ATP or ADP. J. Biol. Chem. 262:11104-11115
Chiara, D.C. et al. (2003) Identification of amino acids in the nicotinic acetylcholine
receptor agonist binding site and ion channel photolabeled by
4-[(3-trifluoromethyl)-3H-diazirin-3-yl]benzoylcholine, a novel photoaffinity antagonist.
Katz, B. and Thesleff, S. (1957) A study of the desensitization produced by acetylcholine
at the motor end-plate. J. Physiol. 138:63-80
Löffler, W. et al. (1982) Influence of dietary purines on pool size, turnover, and
excretion of uric acid during balance conditions. Isotope studies using
15N-uric acid. Res. Exp. Med. Berl 181:113-123
Mehlhaff, D.L. and Stein, D.S. (1996) Gout secondary to ritonavir and didanosine. AIDS
Choi, H.K. et al. (2004) Alcohol intake and risk of incident gout in men: a prospective
study. Lancet 363:1277-1281
Kishibe, M. et al. (2010) Chronic tophaceous gout secondary to self-induced vomiting in
anorexia nervosa. J. Dermatol. 37:578-580
Heuckenkamp, P.U. and Zöllner, N. (1971) Fructose-induced hyperuricaemia. Lancet
Oberhaensli, R.D. et al. (1987) Study of hereditary fructose intolerance by use of
31P magnetic resonance spectroscopy. Lancet
Choi, H.K. and Curhan, G. (2008) Soft drinks, fructose consumption, and the risk of gout
in men: prospective cohort study. BMJ
Colca, J.R. et al. (2013) Identification of a mitochondrial target of thiazolidinedione
insulin sensitizers (mTOT) –relationship to newly identified mitochondrial pyruvate
carrier proteins. PLoS One 8:e61551
Miller, R.A. et al. (2013) Biguanides suppress hepatic glucagon signalling by decreasing
production of cyclic AMP. Nature 494:256-260
Palmer, M. (2003) Efflux of cytoplasmically acting antibiotics from gram-negative
bacteria: periplasmic substrate capture by multicomponent efflux pumps inferred from their
cooperative action with single-component transporters. J.
Marquardt, J.L. et al. (1994) Kinetics, stoichiometry, and identification of the reactive
thiolate in the inactivation of UDP-GlcNAc enolpyruvoyl transferase by the antibiotic
fosfomycin. Biochemistry 33:10646-10651
Johnson, J.W. et al. (2010) Cyclobutanone analogues of β-lactams revisited: insights
into conformational requirements for inhibition of serine- and metallo-β-lactamases.
Chem. Soc. 132:2558-2560
Sulton, D. et al. (2005) Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant
S130G SHV-1 β-lactamase. Insights into the mechanism of inhibition. J. Biol.
Xie, J. et al. (2011) A redesigned vancomycin engineered for dual D-Ala-D-ala And
D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant
bacteria. J. Am. Chem. Soc. 133:13946-13949
Zhanel, G.G. et al. (2010) New lipoglycopeptides: a comparative review of dalbavancin,
oritavancin and telavancin. Drugs 70:859-86
Palmer, A.C. and Kishony, R. (2014) Opposing effects of target overexpression reveal drug
mechanisms. Nat. Commun. 5:4296
Hoang, A.N. et al. (2010) The neutral lipid composition present in the digestive vacuole
of Plasmodium falciparum concentrates heme and mediates \gb-hematin formation with an
unusually low activation energy. Biochemistry 49:10107-10116
Cline, S.D. and Osheroff, N. (1999) Cytosine arabinoside lesions are position-specific
topoisomerase II poisons and stimulate DNA cleavage mediated by the human type II enzymes.
Denning, D.W. and Warn, P. (1999) Dose range evaluation of liposomal nystatin and
comparisons with amphotericin B and amphotericin B lipid complex in temporarily
neutropenic mice infected with an isolate of Aspergillus fumigatus with reduced
susceptibility to amphotericin B. Antimicrob.
Agents Chemother. 43:2592-2599
Rubin, R.P. (2007) A brief history of great discoveries in pharmacology: in celebration of
the centennial anniversary of the founding of the American Society of Pharmacology and
Experimental Therapeutics. Pharmacol. Rev. 59:289-359